The association of adiponectin serum level and ADIPOQ +45 T/G and ADIPOR1 -106 A/G gene polymorphisms with diabetic nephropathy in type 2 DM

被引：0
作者：
Kamal M. [1 ]
Roshdy M. [2 ]
ElKhatib M. [2 ]
机构：
[1] Department of Clinical and Chemical Pathology, Cairo University, Cairo
[2] Department of Internal Medicine, Cairo University, Cairo
来源：
Comparative Clinical Pathology | 2014年 / 23卷 / 1期
关键词：
Adiponectin; ADIPOQ; ADIPOR1; DM; DN;
D O I：
10.1007/s00580-012-1569-4
中图分类号：
学科分类号：
摘要：
Adiponectin encoded by ADIPOQ, gene (adiponectin, C1Q and Collagen Domain-Containing) is an adipocyte-derived protein, plays a major role in mediating insulin sensitivity, and lower plasma adiponectin concentration has been linked to microangiopathies in type 2 diabetes mellitus (DM). It has been hypothesized that blood adiponectin concentration may reflect the extent of kidney damage in diabetic patients. Our aim was to study genetic polymorphisms in adiponectin genes (ADIPOQ +45 T/G and adiponectin receptor 1 (ADIPOR1) -106 A/G) and the serum level of adiponectin in type 2 DM and to correlate this with the stages of diabetic nephropathy. Forty-eight patients with type 2 DM were recruited from Internal Medicine Department and Nephrology Outpatient Clinic in Kasr El Aini Hospital, Cairo University, from April 2011 until March 2012. They were divided into normoalbuminuric (nonnephropathic), n = 17; and nephropathic group, n = 31; who were further subdivided into microalbuminuric, macroalbuminuric, and end-stage renal disease groups. They were compared to ten healthy control subjects. Blood urea, creatinine, HbA1c, and adiponectin were measured. ADIPOQ +45 T/G and ADIPOR1 -106 A/G gene polymorphisms were analyzed by PCR RFLP. Serum adiponectin was significantly lower in nephropathic group versus nonnephropathic and control group (P = 0.026) with the lowest level in macroalbuminuric group (P < 0.001). Serum urea, blood glucose, HbA1c, and duration of diabetes were found to be independent predictors of adiponectin level, r 2 = 0.59. In case of ADIPOQ, most of the cases carried the TT genotype, and there was absence of GG genotype in both cases and control. The ADIPOR1 gene polymorphism was strongly associated with type 2 DM and diabetic nephropathy. The G allele of ADIPOR1 was found to be a risk factor for type 2 DM with OR 3.1 (95 % confidence interval 1.1-8.5), P = 0.028. This evidence highlights the role of ADIPOR1 in the pathogenesis of diabetic nephropathy and type 2 diabetes (T2D), suggesting AdipoR1 as a promising target for the treatment of T2D patients, particularly those who have microalbuminuria. Also, adiponectin serum level is a biomarker for kidney disease and may be targeted for prevention and treatment. © 2012 Springer-Verlag London Limited.
引用
收藏
页码：53 / 60
页数：7
相关论文
共 33 条
  • [1] Ahima R.S., Linking adiponectin to proteinuria, J Clin Invest, 118, 5, pp. 1645-1656, (2008)
  • [2] Diagnosis and classification of diabetes mellitus, Diabetes Care, 31, (2008)
  • [3] An W.S., Son Y.K., Kim S.E., Kim K.H., Bae H.R., Lee S., Park Y., Kim H.J., Vaziri N.D., Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients, Clin Nephrol, 75, 3, pp. 195-203, (2011)
  • [4] Dronavalli S., Duka I., Bakris G.L., The pathogenesis of diabetic nephropathy, Nat Clin Pract Endocrinol Metab, 4, pp. 444-452, (2008)
  • [5] Han L.Y., Wu Q.H., Jiao M.L., Hao Y.H., Liang L.B., Gao L.J., Legge D.G., Quan H., Zhao M.M., Ning N., Kang Z., Associations between single-nucleotide polymorphisms (+45 T > G, +276G > T, -11377C > G, -11391G > A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis, Diabetologia, 54, 9, pp. 2303-2314, (2011)
  • [6] Hattersley A.T., Pearson E.R., Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes, Endocrinology, 147, pp. 2657-2663, (2006)
  • [7] Hu E., Liang P., Spiegelman B.M., AdipoQ is a novel adipose specific gene dysregulated in obesity, J Biol Chem, 271, pp. 10697-10703, (1996)
  • [8] Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors, Endocr Rev, 26, pp. 439-451, (2005)
  • [9] Kollerits B., Fliser D., Heid I.M., Ritz E., Kronenberg F., Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study, Kidney Int, 71, pp. 1279-1286, (2007)
  • [10] Lee Y.J., Cho S., Kim S.R., The association between serum adiponectin levels and nutritional status of hemodialysis patients, Ren Fail, 33, 5, pp. 506-511, (2011)
1234